Literature DB >> 24601689

Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.

Anna Riester1, Evelyn Fischer, Christoph Degenhart, Maximilian F Reiser, Martin Bidlingmaier, Felix Beuschlein, Martin Reincke, Marcus Quinkler.   

Abstract

CONTEXT: Adrenal venous sampling (AVS) is used to distinguish bilateral from unilateral primary aldosteronism (PA). Due to its limited availability, clinical prediction scores have been proposed to diagnose unilateral disease without AVS.
OBJECTIVE: Our goal was to test 2 recently proposed predictors of unilateral PA: 1) a clinical prediction score using imaging, serum potassium, and glomerular filtration rate and 2) the combination of visible unilateral adenoma on imaging and age <40 years. DESIGN AND
SETTING: We used the data of all patients with PA of the prospective German Conn's Registry treated in Munich and Berlin since 2008. PATIENTS AND INTERVENTION: Of 205 patients with PA, 194 had a successful AVS and were included. MAIN OUTCOME MEASURES: Parameters were compared between patients with lateralized and nonlateralized AVS. Specificity and sensitivity of the proposed predictors were calculated.
RESULTS: A total of 130 patients (67%) had unilateral PA according to AVS. Patients with unilateral PA showed a significantly lower estimated glomerular filtration rate compared with patients with bilateral disease (P < .05). The cohorts differed significantly in potassium supplementation, serum potassium, baseline and post-saline plasma aldosterone, baseline aldosterone to renin ratio, and adenoma in imaging. The proposed prediction score had a sensitivity of 46% (58 of 127) and a specificity of 80% (53 of 66). In patients below 40 years (n = 28), the prediction score achieved a specificity of 100%; however, relying only on imaging in this young cohort, the specificity dropped to 83%.
CONCLUSIONS: The suggested prediction score has high accuracy only in young patients but cannot substitute for AVS in the elderly.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24601689     DOI: 10.1210/jc.2013-3789

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  Issues in the Diagnosis and Treatment of Primary Aldosteronism.

Authors:  Jacopo Burrello; Silvia Monticone; Fabrizio Buffolo; Martina Tetti; Giuseppe Giraudo; Domenica Schiavone; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-09

Review 2.  Primary aldosteronism and salt.

Authors:  John W Funder
Journal:  Pflugers Arch       Date:  2014-12-13       Impact factor: 3.657

Review 3.  Secondary Hypertension in Pregnancy.

Authors:  Line Malha; Phyllis August
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

Review 4.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  Favorable surgical outcomes of aldosterone-producing adenoma based on lateralization by CT imaging and hypokalemia: a non-AVS-based strategy.

Authors:  Hai Li; Jianbin Liu; Xiujuan Feng; Liehua Liu; Guohong Wei; Xiaopei Cao; Yanbing Li
Journal:  Int Urol Nephrol       Date:  2017-09-16       Impact factor: 2.370

6.  In situ metabolomics of aldosterone-producing adenomas.

Authors:  Masanori Murakami; Yara Rhayem; Thomas Kunzke; Na Sun; Annette Feuchtinger; Philippe Ludwig; Tim Matthias Strom; Celso Gomez-Sanchez; Thomas Knösel; Thomas Kirchner; Tracy Ann Williams; Martin Reincke; Axel Karl Walch; Felix Beuschlein
Journal:  JCI Insight       Date:  2019-09-05

Review 7.  Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.

Authors:  Gregory L Hundemer
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 8.  Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12       Impact factor: 4.741

9.  Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas.

Authors:  Fang Sun; Yangning Hong; Hexuan Zhang; Xiaoli Liu; Zhigang Zhao; Hongbo He; Zhencheng Yan; Zhiming Zhu
Journal:  BMC Endocr Disord       Date:  2021-05-31       Impact factor: 2.763

10.  The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation.

Authors:  Taweesak Wannachalee; Elaine Caoili; Kazutaka Nanba; Aya Nanba; William E Rainey; James J Shields; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.